Amgen seeks to ease investor concerns as staff cuts loom
With reimbursement limits the latest threat to its anemia franchise, Amgen moved to shore up investor confidence yesterday.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.